These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29525792)

  • 1. New insights into classification, epidemiology and microbiology of SSTIs, including diabetic foot infections.
    Esposito S; Noviello S; De Caro F; Boccia G
    Infez Med; 2018 Mar; 26(1):3-14. PubMed ID: 29525792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and microbiology of skin and soft tissue infections.
    Esposito S; Noviello S; Leone S
    Curr Opin Infect Dis; 2016 Apr; 29(2):109-15. PubMed ID: 26779772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to stratify patients at risk for resistant bugs in skin and soft tissue infections?
    Guillamet CV; Kollef MH
    Curr Opin Infect Dis; 2016 Apr; 29(2):116-23. PubMed ID: 26779773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of Skin and Soft Tissue Infections (SSTIs).
    Esposito S; De Simone G; Gioia R; Noviello S; Pagliara D; Campitiello N; Rubino C; Lo Pardo D; Boccia G; De Caro F; Ascione T
    J Chemother; 2017 Jun; 29(3):154-158. PubMed ID: 27376439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of diabetic foot infections.
    Joseph WS
    Cutis; 2004 May; 73(5 Suppl):20-2. PubMed ID: 15182162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gram-Negative Skin and Soft Tissue Infections.
    Jabbour JF; Kanj SS
    Infect Dis Clin North Am; 2021 Mar; 35(1):157-167. PubMed ID: 33303333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin and soft tissue infection: microbiology and epidemiology.
    Dryden MS
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S2-7. PubMed ID: 19560670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complicated skin and soft tissue infection.
    Dryden MS
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 3():iii35-44. PubMed ID: 20876627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
    Hau T
    Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):491-8. PubMed ID: 12172739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe soft tissue infections.
    Napolitano LM
    Infect Dis Clin North Am; 2009 Sep; 23(3):571-91. PubMed ID: 19665084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
    Cardona AF; Wilson SE
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S69-78. PubMed ID: 26316560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
    Mendes RE; Farrell DJ; Sader HS; Flamm RK; Jones RN
    J Antimicrob Chemother; 2015 Feb; 70(2):498-504. PubMed ID: 25362568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin and soft tissue infections: classification and epidemiology].
    Esposito S; Leone S; Petta E; Noviello S; Iori I
    Infez Med; 2009 Sep; 17 Suppl 4():6-17. PubMed ID: 20428017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship.
    Jenkins TC; Sabel AL; Sarcone EE; Price CS; Mehler PS; Burman WJ
    Clin Infect Dis; 2010 Oct; 51(8):895-903. PubMed ID: 20839951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.
    Stevens DL
    J Infect; 2009 Sep; 59 Suppl 1():S32-9. PubMed ID: 19766887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complicated skin and soft-tissue infections--consider gram-negative pathogens.
    Ruef C
    Infection; 2008 Aug; 36(4):295. PubMed ID: 18663409
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
    Tsoulas C; Nathwani D
    Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA.
    Harch SAJ; MacMorran E; Tong SYC; Holt DC; Wilson J; Athan E; Hewagama S
    BMC Infect Dis; 2017 Jun; 17(1):405. PubMed ID: 28592231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.